Drug delivery inhaler devices
The present invention provides an adapter for fitting to a drug delivery device, the adapter comprising: an outlet for communication with the mouth of a patient; an air flow path through the adapter along which air is drawn to the outlet by inhalation by the patient; an inlet adapted for connection to a mouthpiece of the drug delivery device; and an air flow rate indicator operable to indicate when the air flow rate along the air flow path is at or above a predetermined minimum level suitable for delivery of the drug to the patient. The present invention also provides a drug delivery device having, in its body, an air flow rate indicator operable to indicate when the air flow rate along the air flow path is at or above a predetermined minimum level suitable for delivery of the drug to the patient.
1. A drug delivery inhaler device having:
an L-shaped body with an upright portion for housing a drug reservoir and terminating at an air inlet and a transverse portion terminating at an outlet for communication with the mouth of a patient;
an air flow path through the device along which air is drawn from the air inlet of the upright portion of the body to the outlet by inhalation by the patient;
a seat for location of a drug reservoir, the drug reservoir being operable to deliver a dose of aerosolized drug into the air flow path for inhalation by the patient; and
an air flow rate indicator operable to continuously indicate when the air flow rate along the air flow path is at or above a predetermined minimum level suitable for delivery of the drug to the patient both before and during delivery of the drug,
wherein said air flow indicator is provided in the airflow path at or proximate the air inlet of the upright portion of the body upstream from the point at which the dose of aerosolized drug is ejected into the air flow path.
2. The drug delivery inhaler device according to claim 1 wherein the device is a pressurised metered dose inhaler (pMDI) device.
3. The drug delivery inhaler device according to claim 1 wherein the predetermined minimum air flow rate through the device is at least 30 liters per minute.
4. The drug delivery inhaler device according to claim 1 wherein the air flow rate indicator is adapted to generate an audible or visual signal.
5. The drug delivery inhaler device according to claim 1 wherein the air flow rate indicator is operable electronically.
6. The drug delivery inhaler device of claim 1 , wherein the air flow rate indicator comprises a reed configured to oscillate to generate an audible signal.
7. The drug delivery inhaler device of claim 6 , wherein the reed is disposed in an aperture in a side wall of the L-shaped body.
8. The drug delivery inhaler device of claim 1 , wherein, in use, the air flow rate indicator is configured to be positioned upstream of a base of the drug reservoir and downstream of a top end of the drug reservoir in the air flow path.
9. A drug delivery inhaler device having:
an L-shaped body with an upright portion configured for receiving a drug reservoir and terminating at an air inlet and a transverse portion terminating at an outlet for communication with the mouth of a patient;
an air flow path through the device along which air is drawn from the air inlet of the upright portion of the body to the outlet by inhalation by the patient; and
an air flow rate indicator operable to continuously indicate when the air flow rate along the air flow path is at or above a predetermined minimum level suitable for delivery of an aerosolized drug to the patient both before and during delivery of the drug,
wherein said air flow indicator is provided in the airflow path at or proximate the air inlet of the upright portion of the body.
10. The drug delivery inhaler device of claim 9 , wherein the air flow rate indicator comprises a reed configured to oscillate to generate an audible signal.
11. The drug delivery inhaler device of claim 10 , wherein the reed is disposed in an aperture in a side wall of the L-shaped body.
12. The drug delivery inhaler device of claim 9 , wherein, in use, the air flow rate indicator is configured to be positioned upstream of a base of the drug reservoir and downstream of a top end of the drug reservoir in the air flow path.